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INTRODUCTION
Paeonol (2'-hydroxy-4'-methoxyacetophenone), a micromolecular phenolic compound ( Fig. 1) , has been isolated from the root bark of the plant Paeonia moutan. Paeonol is traditionally used as a Chinese herbal medicine that has been widely used in sedation, hypnosis, antipyresis, analgesia, antioxidation, anti-infl ammation, anti-bacterial and to activate the blood fl ow and remove blood stasis (Dai et al., 2000; Mimura and Baba, 2001; Chou, 2003; Zhang et al., 2011) . Paeonol shows antitumor effects and inhibits the proliferation of different tumor cell lines, e.g. the K562, T6-17, Bel-7404, Hela and HT-29 etc. Certain mechanisms of paeonol antitumor induce tumor cell apoptosis and enhance the activity of various immune molecules. The induction of apoptosis was associated with a decrease of the ratio of Bcl-2/bax, an increase of fas/fasl and caspase 3 expression in HepA hepatoma mice (Pan et al., 2004; and human esophageal cancer cell lines (Sun et al., 2004; Liu et al., 2005; Wan et al., 2008) . The previous study confi rmed that paeonol inhibited the growth of tumor cells by reducing the expression of mutant p53, Bcl-2 and C-erbB-2 proteins in tumor tissues in mice bearing EMT6 breast cancer . No detailed report was carried out on the mechanism of paeonol against breast cancer through the induction of apoptosis. Therefore, the present study further investigated the possible mechanisms responsible for the antitumor activity of paeonol using EMT6 bearing mice. The purpose was to explore the therapeutic potential of paeonol for breast cancer and to provide a scientifi c explanation for the traditional application of this particular herbal medicine in breast cancer therapy.
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MATERIALS AND METHODS

Materials
Animals
Fifty female 6-week-old Kunming mice were purchased from the Laboratory Animal Center of the Academy of Military Me dical Sciences. The mice were randomly divided into fi ve groups (n=10 per group). One group was used for the preparation of EMT6 tumor cells. The other four groups were used for different administrations (see details in the section: Animal model and drug treatment). Animals were housed in plastic cages with free access to food and water and maintained on a regulated environment (20 ± 2 o C). All animal experiments were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals (NIH Publication No.80-23; revised 1978 and the number approved by AdministratedCommittee of Laboratory Animals was 062310).
Preparation of EMT6 tumor cells
The EMT6 breast cancer cell line (10 7 cell/ml) was injected into the right forelimb in one group of mice (0.2 ml/mouse). When each tumor had grown to 1 cm in size, it was removed and suspended in normal saline to a concentration of 5×10 6 cell/ml under aseptic conditions.
Animal model and drug treatment
Four groups of mice were all injected with 0.2 ml/mouse of 5×10 6 cell/ml EMT6 breast cancer cells in the skin under the right forelimb. After 24h inoculation, one group was administered with vehicle alone (distilled water, p.o.) as the control group. One group was given the standard antitumor reference drug cyclophosphamide (CTX, 25 mg/kg body weight, i.p.), which was designated as the positive control group, the CTX group. The other two groups were administrated paeonol, low dosage (150 mg/kg body weight, p.o.) and high dosage (300 mg/kg body weight, p.o.). After 15 days, all mice were weighed and killed; each tumor was removed and weighed. According to the mean weight of the tumor, the rate of tumor inhibition was calculated as follows: the rate of inhibition (%)=[(mean tumor weight of Control group-mean tumor weight of Treated group)÷mean tumor weight of Control group]×100.
Morphological analysis of tumor tissues
Tumor specimens which were collected from the control group, CTX group and Paeonol group (300 mg/kg) were fi xed in 10% (v/v) neutral formalin solution, dehydrated through a graded ethanol series and embedded in paraffi n. Tissue sections (4 μm) were stained with hematoxylin and eosin and examined under the light microscope.
TUNEL assay
Apoptotic cells in sections of mice tumor tissues from the four groups were detected by using an in situ apoptosis detection kit according to the manufacturer's instructions. Tissue sections were treated by dewaxing and hydration, fi rstly, according to a conventional method, and then processed with 10 mg/ml protease K for 30 minutes at room temperature. The slides were immersed in a 2% H 2 O 2 solution to block endogeneous peroxidase activity after rinsing 3 times in PBS. Terminal Deoxynucleotidyl Transferase (TdT) was used to ca talyze the addition of Biotin-conjugated dUTP to the 3'-OH ends of DNA fragments. 50 μl TdT enzyme reaction solution was added to each sample except for the control group and covered for 60 minutes at 37 o C. After washing 3 times in PBS, 50 μl Streptavidin-HRP solution was added and reacted for 30 minutes at 37 o C. Finally, DAB staining was carried out and apoptotic cells were detected under a light microscope.
Immunohistochemical analysis of Bcl-2, Bax and caspase-8 in tumor tissues
Tumor specimens which were collected from the four groups were fi xed in 10% (v/v) neutral formalin solution and embedded in paraffi n. Tumor sections were prepared and used to examine the expression of Bcl-2, Bax and caspase-8 proteins. The tumor sections were stained by the standard immunohistochemical streptavidin peroxidase method which was described in the program of streptavidin peroxidasereagents kit. Previously known positive tumor tissues were used as a positive control for Bcl-2, Bax and caspase-8. The cells which stained brown suggest positive cells while cells stained blue indicate negative cells under the microscope. The immunohistochemical results were quantitatively analyzed using a biological image analysis system and biological image analysis software (Leica Microsystems Ltd. Germany). The average positive rate was analyzed by microscopy using six randomly selected optical fi elds (200 cells per fi eld).
Western blot analysis for Bcl-2, Bax, caspase 8 and caspase 3
Tumor tissues from the four groups were minced and lysed in 500 μl cell lysis buffer for 30 minutes, and centrifuged at 12,000 g for 15 minutes at 4°C. The supernatant was collected and protein concentrations were determined according to the Bradford method. Samples were subjected to 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) after which they were boiled for 5 minutes, and the resolved proteins were electrophoretically transferred to polyvinylidene difl uoride membranes by a semi-dry transfer method. The membranes were blocked with 5% non-fat dried milk in Trisbuffered saline containing 0.1% Tween 20 (TBST) for 1 hour at room temperature, washed three times with TBST, and incubated with TBST containing 5% of dried skim milk and primary antibody (Bcl-2, Bax, caspase 8 or caspase 3) for 2 hours at www.biomolther.org room temperature. After washing three times with TBST, the membranes were incubated with horseradish peroxidase-conjugated secondary antibody for 1 hour at room temperature. Proteins were visualized by using an enhanced chemiluminescence kit and exposed to X-ray fi lm. At the same time, actin was used as an internal control for all Western blots. The intensity of protein bands was quantifi ed by using LabWork 3.0 UVP software (UVP, Upland, CA, USA).
Statistical analysis
All values are expressed as mean ± S.D. One-way analysis of variance and Duncan's multiple range tests were used for determining differences among groups, and p<0.05 was regarded as statistically signifi cant.
RESULTS
Cytotoxicity of paeonol on mice breast cancer
After tumor-bearing mice were treated with two dosages of paeonol 150 or 300 mg/kgbody weight and CTX for 15 days, there was no signifi cant infl uence on the body weight of mice in both CTX group and Paeonol group. However, comparing with the control group to the groups administered with paeonol of 150 mg/kg and 300 mg/kg the tumor weight signifi cantly decreased and the tumor inhibition rate was 41.25% and 51.05%, respectively. CTX, which is the standard chemotherapeutic, produced an inhibition rate of 53.84% (Table 1) .
Morphological analysis of cell apoptosis
Tumor cells in the control group were arranged closely in different shapes and sizes, the cells displayed a small cytoblastema and a larger nucleus which was thickly stained and obvious heteromorphism, and hyperplasia. As shown in Fig.  2 , the number of tumor cells in the Paeonol treatment groups decreased markedly, and tumor cell chromatin accumulated at the side of the nucleic membranes. The nucleic shapes were irregular and the surface of the nucleic membrane was rough. The nucleus was broken but it was encapsulated by intact membrane, containing intact organelles and apoptotic bodies. Comparing it with the Control group, there were more apoptotic cells in the Paeonol group under a light microscopy (Fig. 2) . TUNEL staining results depicted that the apoptotic index reached 19.72% in the Paeonol group (300 mg/kg body weight) (Table 2, Fig. 3 ), this demonstrated that paeonol treatment produced markedly more apoptotic cells.
Eff ects of paeonol on the expression of Bcl-2, Bax and Caspase-8
The S-P immunohistochemical method was used to exam- Fig. 6 ).
Eff ects of paeonol on the expression of Bcl-2, Bax, caspase 8 and caspase 3 proteins by Western Blot
To further defi ne the effects of paeonol on tumor cells associated with the apoptotic pathway, protein levels of Bcl-2, Bax, caspase 8 and caspase 3 were evaluated by Western Blot. As shown in Fig. 7 , the expression of Bcl-2 decreased no ticeably, whereas the protein expression of Bax, caspase 8 and caspase 3 increased in the CTX and paeonol groups. 
DISCUSSION
This study is further investigation into the effects and mechanisms of paeonol on mice harboring breast cancer cells. The results demonstrated that the paeonol plays an important antitumor role. Compared with the control group, paeonol administration can signifi cantly decrease the tumor weight and increase the tumor inhibition rates; induce morphological changes indicative of apoptosis; increase tumor cell apoptosis; and regulate the expression of Bcl-2 and Bax, leading to a decrease of the ratio of Bcl-2/Bax; increase the activity of caspase 8 and caspase 3. The fi ndings are consistent with previous studies using paeonol which showed Bcl-2 down-regulation, Bax and caspase-3 activation in mouse HepA-hepatoma and human colon cancer cell lines Li et al., 2010; Xing et al., 2010) .
Apoptosis, also called programmed cell death, is an evolutionarily conserved genetic program of cellular characteristics. It is well recognized that an alteration of the cellular homeostasis occurs in cancer, which disrupts the balance between cellular proliferation and cell death (apoptosis). Apoptosis is also a form of cell death which is characterized morphologically by extreme chromatin condensation and formation of apoptotic bodies (Zhang et al., 2008; Wang et al., 2012) . Many anticancer drugs induce tumor cell apoptosis which is an obvious strategy for cancer therapy.
The mechanisms of apoptosis induced by drugs are complex due to the differences in cell types and drugs (Li et al., 2011) . However, mitochondrial and cell-surface death receptor-mediated apoptosis are the two principal pathways leading to programmed cell death. The mitochondrial pathway is thought to play a major role in response to cancer treatments and is mediated by the Bcl-2 family proteins, which are always over-expressed in many tumor cells (Reed, 2000; Sjöström et al., 2002; Ohtsuka et al., 2003) and they act as repressors of apoptosis by blocking the release of cytochrome-c, whereas proapoptotic members, e.g., Bax, act as promoters. These effects are more dependent on the balance between Bcl-2 and Bax than on Bcl-2 quantity alone.
In the current study, the treatment with paeonol decreased the expression of Bcl-2 and increased the expression of Bax. The up-regulation of Bax expression and the reduction of Bcl-2 expression in the treated groups leads to a decrease in the ratio of Bcl-2 to Bax, which might be responsible for the druginduced apoptotic processes and which might be associated with better prognosis.
Caspase 8, an initiator of apoptosis, could be activated under the stimulation of external signals. Activated caspase 8 continues to cleave procaspase 3 into active caspase 3 to achieve apoptosis. Caspase 3 is an executioner caspase of the apoptosis pathway (Mlejnek, 2001; Cheung et al., 2002) . In the present study, after administration with paeonol there was a considerable increase in caspase 8 and caspase 3 expressions, which indicated that paeonol promoted caspase 8 and caspase 3 activation.
The results of the study demonstrate that paeonol has the effect of inhibiting the growth of tumor cells. The mechanism of inhibition by inducing apoptosis could possibly occur through the triggering of the mitochondrial-dependent pathway and caspase activation. Paeonol, a traditional natural plant compound, may be a novel chemotherapy against breast cancer.
